Chronic myocardial ischemia: contemporary management strategies
1Angiogenesis Research Center and Interventional Cardiology Section, Department of Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
Insights
Chronic myocardial ischemia, often due to advanced coronary disease, involves oxygen supply-demand imbalance. New therapies focus on stimulating new blood vessel growth for improved heart perfusion.
Area of Science:
- Cardiovascular Medicine
- Regenerative Medicine
Background:
- Chronic myocardial ischemia indicates an imbalance in oxygen supply and demand, typically linked to advanced atherosclerotic coronary disease.
- Traditional treatments focus on reducing oxygen demand or enhancing blood flow in existing coronary vessels.
Purpose of the Study:
- To explore evolving therapeutic strategies for chronic myocardial ischemia.
- To highlight novel approaches beyond standard medical and interventional therapies.
Main Methods:
- Review of established therapies including pharmacologic agents, coronary bypass grafting, and coronary angioplasty.
- Examination of emerging strategies involving the stimulation of new coronary vessel growth (angiogenesis).
Main Results:
- Standard therapies aim to manage oxygen demand or improve flow through compromised vessels.
- Novel approaches focus on promoting neovascularization to enhance myocardial perfusion.
Conclusions:
- While established treatments remain crucial, new methods stimulating new vessel growth offer a promising evolving strategy for myocardial perfusion.
- Stimulation of new coronary vessel growth, via growth factors or mechanical means, represents a paradigm shift in treating chronic myocardial ischemia.
Abstract:
The presence of chronic myocardial ischemia signifies an imbalance between myocardial oxygen supply and demand that usually reflects the existence of advanced atherosclerotis coronary disease. Standard therapies for this condition that have evolved over the past 40 years include drugs primarily designed to reduce myocardial oxygen demand or improve flow through the existing vessels. In a select group of patients this approach is supplemented by coronary bypass grafting or coronary angioplasty. A new and currently evolving approach relies on stimulation of growth of new coronary vessels to improve myocardial perfusion that can be achieved either by the application of growth factors or mechanical means.
More Related Videos
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Angina V: Nursing Management
Atherosclerosis III: Management
